The Bitter-Sweet Symphony Of Cancer: Integrins And Glycans
Share This:

About The Author

Abhay Pandit is the Director of a Science Foundation Ireland  funded Centre for Research in Medical Devices (CÚRAM) at the the National University of Ireland, Galway. Prof Pandit’s postgraduate work focussed on the modification of a fibrin scaffold to deliver a therapeutic biomolecule and resulted in a clinical trial at the Burn Centre at the University of Alabama at Birmingham. Prof. Pandit is listed in the International Who's Who of Professionals and is listed in Who's Who in American Universities. Prof. Pandit's subsequent research in the Wound Care R & D Group at The Kendall Company resulted in a patent and FDA approval for a commercial wound dressing. Prof. Pandit led the Biomaterials Research Group at Surgical Sealants, Inc. where he received IDE approval for a collagen-based vascular sealant. He has received FDA 510k approval for a hydrophilic wound dressing. Prof Pandit has over twenty-five years of experience in the field of biomaterials. After a seven-year stint in industry he has worked in academia for the last twelve years.


The Bitter-Sweet Symphony Of Cancer: Integrins And Glycans

In the United States, half of all women and one-third of all men will develop cancer in their lifetime. A similar rate has been reported for the United Kingdom and Ireland. Cancer arises when just one cell in the body loses control and starts to multiply in too large of quantities. But what causes a cell to “lose control”? One reason is the abnormal function of a protein called an integrin. Integrins are proteins that are embedded inside the cell...

Read more